2-Cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
Common Name: |
2-Cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide |
IUPAC Name: |
2-(ethylcarbamoylamino)-N-methoxy-2-oxoethanimidoyl cyanide |
Molecular Formula: |
C7H10N4O3 |
SMILES: |
CCNC(=O)NC(=O)C(=NOC)C#N |
Inchi: |
1S/C7H10N4O3/c1-3-9-7(13)10-6(12)5(4-8)11-14-2/h3H2,1-2H3,(H2,9,10,12,13) |
Inchi Key: |
XERJKGMBORTKEO-UHFFFAOYSA-N |
Cas No: |
166900-80-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
198.18 |
Mass (g/mol) |
198.075 |
Molar Refractivity |
46.67 |
Net Charge |
|
HBD |
2 |
HBA |
5 |
Rt Bonds |
6 |
Rings |
|
TPSA |
103.58 |
Hetero Atoms |
7 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.43 |
LogP |
-0.642 |
iLOGP |
-0.30 |
XLOGP3 |
0.59 |
WLOGP |
-0.64 |
MLOGP |
-1.22 |
ESOL Log S |
-1.04 |
ESOL Solubility (mg/ml) |
17.9 |
ESOL Solubility (mol/l) |
0.09 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.34 |
Ali Solubility (mg/ml) |
0.91 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-0.98 |
Silicos-IT Solubility (mg/ml) |
20.5 |
Silicos-IT Solubility (mol/l) |
0.1 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.09 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.064 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.812 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |